These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17718058)

  • 61. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
    Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA
    Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib.
    Anargyrou K; Terpos E; Vassilakopoulos TP; Pouli A; Sachanas S; Tzenou T; Masouridis S; Christoulas D; Angelopoulou MK; Dimitriadou EM; Kalpadakis C; Tsionos K; Panayiotidis P; Dimopoulos MA; Pangalis GA; Kyrtsonis MC;
    Haematologica; 2008 Mar; 93(3):451-4. PubMed ID: 18287135
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spurious hypophosphatemia in a patient with multiple myeloma.
    Loghman-Adham M; Walton D; Iverius PH; Deiss A; Knight JA; Cheung AK
    Am J Kidney Dis; 1997 Oct; 30(4):571-5. PubMed ID: 9328375
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis.
    Van Beneden K; Coppieters K; Laroy W; De Keyser F; Hoffman IE; Van den Bosch F; Vander Cruyssen B; Drennan M; Jacques P; Rottiers P; Verbruggen G; Contreras R; Callewaert N; Elewaut D
    Ann Rheum Dis; 2009 Aug; 68(8):1360-5. PubMed ID: 18772190
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IgG glycosylation status as a clinical predictor of rheumatoid arthritis: comment on the article by Kim and Weisman.
    Isenberg DA; Young A
    Arthritis Rheum; 2000 Nov; 43(11):2617-8. PubMed ID: 11083296
    [No Abstract]   [Full Text] [Related]  

  • 66. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [N-glycosylation of proteins in rheumatic diseases].
    Hrycaj P; Müller W
    Z Rheumatol; 1992; 51(2):51-4. PubMed ID: 1377440
    [No Abstract]   [Full Text] [Related]  

  • 68. [Serum glycoproteins in some blood diseases (chronic leukosis, acute leukosis, malignant lymphogranulomas, plasmocytomas). Total hexoses bound to proteins, mucoproteins, hexosamines].
    CAMPANINI H; PEROLINI G
    Minerva Med; 1961 Apr; 52():1530-5. PubMed ID: 13690192
    [No Abstract]   [Full Text] [Related]  

  • 69. Studies on "abnormal" serum globulins (M-components) in myeloma, macroglobulinemia and related diseases.
    HEREMANS JF; LAURELL AH; MARTENSSON L; HEREMANS MT; LAURELL CB; SJOQUIST J; WALDENSTROM J
    Acta Med Scand Suppl; 1961; 367():1-126. PubMed ID: 13713569
    [No Abstract]   [Full Text] [Related]  

  • 70. Interview with Ivan M. Roitt. What is going to happen tomorrow as far as glycosylation of IgG is concerned?. Interview by P. Youinou.
    Roitt IM
    Ann Med Interne (Paris); 1993; 144(6):389-91. PubMed ID: 8122821
    [No Abstract]   [Full Text] [Related]  

  • 71. [IgG multiple myeloma of 13 years of development].
    López-Cubero L; Gómez-Octavio J; Martín-Calderín F
    Sangre (Barc); 1995 Oct; 40(5):436-7. PubMed ID: 8553183
    [No Abstract]   [Full Text] [Related]  

  • 72. Trace N-glycans including sulphated species may originate from various plasma glycoproteins and not necessarily IgG.
    Lauc G; Vučković F; Bondt A; Pezer M; Wuhrer M
    Nat Commun; 2018 Jul; 9(1):2916. PubMed ID: 30046098
    [No Abstract]   [Full Text] [Related]  

  • 73. Serum protein turnover in multiple myeloma.
    BERSON SA; YALOW RS
    J Lab Clin Med; 1957 Mar; 49(3):386-94. PubMed ID: 13406370
    [No Abstract]   [Full Text] [Related]  

  • 74. An unexpected rise in cardiac troponin I in a patient with multiple myeloma.
    Domanski O; Maréchaux S; Forzy G; Lemahieu JM
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23242077
    [No Abstract]   [Full Text] [Related]  

  • 75. Letters to the editor: Antithrombin and antithromboplastin activity accompanying IgG myeloma.
    Hensen A; Loeliger EA
    Am J Clin Pathol; 1975 Dec; 64(6):820-2. PubMed ID: 1202940
    [No Abstract]   [Full Text] [Related]  

  • 76. [Protein abnormalities in multiple myeloma: atypic biological forms and origin of the myelomatous porteins].
    SERRE H; JAFFIOL C
    Presse Med (1893); 1958 Dec; 66(91):2044-7. PubMed ID: 13623734
    [No Abstract]   [Full Text] [Related]  

  • 77. [Properties and composition of serum albumin in multiple myeloma].
    CAPUTO A
    Z Krebsforsch; 1955; 60(3):372-8. PubMed ID: 14386976
    [No Abstract]   [Full Text] [Related]  

  • 78. [Serum gel reaction as the screening test of paraproteinemia)].
    Ito C; Kano A; Ishitoya Y; Onodera K
    Rinsho Byori; 1966 Nov; 14(11):765-8. PubMed ID: 6009732
    [No Abstract]   [Full Text] [Related]  

  • 79. Protein abnormalities in serum and urine in patients with multiple myeloma.
    PAGET M
    J Sci Med Lille; 1955 May; 73(5):217-33. PubMed ID: 14392658
    [No Abstract]   [Full Text] [Related]  

  • 80. Authors' Reply to the Commentary in the journal of Electrophoresis regarding "The effect of simulated space radiation on the N-glycosylation of human immunoglobulin G1" by J.J. Bevelacqua and S.M.J. Mortazavi.
    Guttman A; Szilasi S; Donczo B; Szarka M
    Electrophoresis; 2018 Nov; 39(22):2851-2853. PubMed ID: 30101988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.